a year ago
PEN
AnalystsPriya SachdevaPriya Sachdeva's Stock Forecasts
AnalystsPriya Sachdeva
Sectors:
Analyst Ranking
Top 36%
#1954 out of 5511 analysts
Average Return
+16.53%
Win Rate
89%8 out of 9
Risk vs Reward
Poor
Good
Priya Sachdeva's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Atricure IncATRC | +41.43% | $39.75 | $56.22 | 2026-07-28 - 2026-09-15 | Strong Buy |
Penumbra IncPEN | +32.53% | $268.20 | $355.44 | 2025-01-21 - 2026-01-20 | Strong Buy |
Neuropace IncNPCE | +26.49% | $13.06 | $16.52 | 2025-01-21 - 2026-01-20 | Strong Buy |
Penumbra IncPEN | +25.93% | $254.21 | $320.13 | 2025-07-30 - 2026-07-29 | Strong Buy |
Penumbra IncPEN | +12.37% | $303.76 | $341.32 | 2025-02-19 - 2026-02-18 | Strong Buy |
Priya Sachdeva Analyst Color
Get additional color on Priya Sachdeva's coverage of popular stocks
Priya Sachdeva's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medtronic PLCMDT | 4 | Strong Buy | $110.00 | +17.33% | Maintains | 13 days ago |
Atricure IncATRC | 1 | Strong Buy | $50.00 | -11.06% | Maintains | 2 months ago |
Neuropace IncNPCE | 2 | Strong Buy | $22.00 | +54.39% | Maintains | 9 months ago |
Penumbra IncPEN | 4 | Strong Buy | $335.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.